Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
American Oncology Network Inc (AONCW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: AONCW (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit 170.5% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.61 | 52 Weeks Range 0.04 - 1.83 | Updated Date 06/8/2025 |
52 Weeks Range 0.04 - 1.83 | Updated Date 06/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 8989380 |
Shares Outstanding - | Shares Floating 8989380 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
American Oncology Network Inc
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018. AON aims to create a network of community oncology practices, focusing on expanding access to cancer care and providing integrated services.
Core Business Areas
- Physician Partnership: AON partners with community oncology practices, providing administrative support, technology, and resources to enhance patient care and practice efficiency.
- Integrated Services: AON offers integrated services such as pharmacy, clinical trials, and care management to enhance patient care and practice efficiency.
Leadership and Structure
AON is led by a management team focusing on oncology practice management. The organizational structure includes regional and operational teams supporting partner practices.
Top Products and Market Share
Key Offerings
- Practice Management Services: AON provides administrative and operational support to oncology practices, including billing, HR, and IT. Market share is not publicly available. Competitors include McKesson, Cardinal Health, and AmerisourceBergen.
- Pharmacy and Dispensing: AON offers in-house pharmacy services and medication dispensing for patients. Market share is not publicly available. Competitors include CVS Health, Walgreens Boots Alliance, and OptumRx.
- Clinical Trial Support: AON provides assistance in running oncology-related clinical trials. Market share is not publicly available. Competitors include research organizations that focus on cancer such as Sarah Cannon Research Institute.
Market Dynamics
Industry Overview
The oncology market is growing due to an aging population and increasing cancer incidence. The industry is characterized by advancements in treatment options, rising healthcare costs, and regulatory changes.
Positioning
AON positions itself as a facilitator for community oncology practices, providing resources to remain competitive. It aims to provide high-quality cancer care in local communities.
Total Addressable Market (TAM)
The global oncology market is expected to reach hundreds of billions of dollars. AON is positioned to capture a share of this TAM by supporting community oncology practices.
Upturn SWOT Analysis
Strengths
- Established network of community oncology practices
- Integrated service offerings
- Focus on improving patient care
- Strong management team
Weaknesses
- Reliance on partner practices
- Limited brand recognition compared to larger players
- Possible impact of regulatory changes or changes in reimbursement policies
- Financial dependence on successful integration and growth of partnered practices.
Opportunities
- Further expansion of the partner network
- Growth in integrated services
- Development of new treatment protocols and partnerships
- Increase in cancer diagnoses drives service demand.
Threats
- Increased competition from other oncology networks
- Changes in healthcare regulations
- Consolidation of healthcare providers
- Economic downturn affecting cancer treatment investment.
Competitors and Market Share
Key Competitors
- McKesson (MCK)
- Cardinal Health (CAH)
- AmerisourceBergen (ABC)
Competitive Landscape
AON focuses on community practices, while competitors are broader healthcare service providers. AON advantages include specialized focus on community oncology.
Growth Trajectory and Initiatives
Historical Growth: Historical growth information is not available to the public, but AON has been expanding its network of practices steadily.
Future Projections: Future projections are unavailable as AON is privately held; however, they plan to further grow their network.
Recent Initiatives: Recent initiatives include adding practices to its network and improving integrated services.
Summary
American Oncology Network aims to support community oncology practices by providing integrated service offerings, enhancing patient care and practice efficiency. As a private entity, their financial performance lacks public insights. They must carefully manage network growth, monitor industry dynamics, and counter competition. Success depends on sustaining relationships with its partner practices, executing its strategy, and adapting to the evolution in healthcare.
Peer Comparison
Sources and Disclaimers
Data Sources:
- American Oncology Network Website
- Industry Reports
- Third-party analysis
Disclaimers:
Data is based on available public information and may be limited. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-13 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.